The Who, What, When, Where, and Why of Bacillus Calmette-Guérin-unresponsive Bladder Cancer

Roger Li; Seth P. Lerner; Ashish M. Kamat

doi:10.1016/j.eururo.2021.01.001

The Who, What, When, Where, and Why of Bacillus Calmette-Guérin-unresponsive Bladder Cancer

Roger Li, Seth P. Lerner, Ashish M. Kamat

Urology

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Abstract

There are several clinical scenarios that may not adhere to the precise definition of bacillus Calmette-Guérin (BCG)-unresponsive bladder cancer, but nevertheless indicate treatment unresponsiveness. We describe four such scenarios as a frame of reference in order to reach a consensus on the enrollment of such patients to current and future clinical trials in the BCG-unresponsive setting.

Original language	English (US)
Pages (from-to)	437-439
Number of pages	3
Journal	European urology
Volume	79
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2021.01.001
State	Published - Apr 2021

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2021.01.001

Cite this

@article{b53334004bb5462886d3561fdb3cbb93,

title = "The Who, What, When, Where, and Why of Bacillus Calmette-Gu{\'e}rin-unresponsive Bladder Cancer",

abstract = "There are several clinical scenarios that may not adhere to the precise definition of bacillus Calmette-Gu{\'e}rin (BCG)-unresponsive bladder cancer, but nevertheless indicate treatment unresponsiveness. We describe four such scenarios as a frame of reference in order to reach a consensus on the enrollment of such patients to current and future clinical trials in the BCG-unresponsive setting.",

author = "Roger Li and Lerner, {Seth P.} and Kamat, {Ashish M.}",

note = "Publisher Copyright: {\textcopyright} 2021 European Association of Urology",

year = "2021",

month = apr,

doi = "10.1016/j.eururo.2021.01.001",

language = "English (US)",

volume = "79",

pages = "437--439",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - The Who, What, When, Where, and Why of Bacillus Calmette-Guérin-unresponsive Bladder Cancer

AU - Li, Roger

AU - Lerner, Seth P.

AU - Kamat, Ashish M.

PY - 2021/4

Y1 - 2021/4

N2 - There are several clinical scenarios that may not adhere to the precise definition of bacillus Calmette-Guérin (BCG)-unresponsive bladder cancer, but nevertheless indicate treatment unresponsiveness. We describe four such scenarios as a frame of reference in order to reach a consensus on the enrollment of such patients to current and future clinical trials in the BCG-unresponsive setting.

AB - There are several clinical scenarios that may not adhere to the precise definition of bacillus Calmette-Guérin (BCG)-unresponsive bladder cancer, but nevertheless indicate treatment unresponsiveness. We describe four such scenarios as a frame of reference in order to reach a consensus on the enrollment of such patients to current and future clinical trials in the BCG-unresponsive setting.

UR - http://www.scopus.com/inward/record.url?scp=85099433647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099433647&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2021.01.001

DO - 10.1016/j.eururo.2021.01.001

M3 - Editorial

C2 - 33454163

AN - SCOPUS:85099433647

SN - 0302-2838

VL - 79

SP - 437

EP - 439

JO - European urology

JF - European urology

IS - 4

ER -

The Who, What, When, Where, and Why of Bacillus Calmette-Guérin-unresponsive Bladder Cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this